Advanced search
Publication Cover
mAbs Volume 12, 2020 - Issue 1
Submit an article Journal homepage
4,217
Views
8
CrossRef citations to date
0
Altmetric
Back Matter

Harnessing MerTK agonism for targeted therapeutics

Vivekananda Kedagea Department of Molecular Oncology, Genentech, South San Francisco, CA, USAORCID Iconhttps://orcid.org/0000-0001-9991-3245
ORCID Icon,
Diego Ellermanb Department of Protein Chemistry, Genentech, South San Francisco, CA, USA
,
Yongmei Chenc Department of Antibody Engineering, Genentech, South San Francisco, CA, USAORCID Iconhttps://orcid.org/0000-0002-4696-0782
ORCID Icon,
Wei-Ching Liangc Department of Antibody Engineering, Genentech, South San Francisco, CA, USAORCID Iconhttps://orcid.org/0000-0002-4082-6881
ORCID Icon,
Joven Borneod Department of Immunology and Infectious Diseases, Genentech, South San Francisco, CA, USAORCID Iconhttps://orcid.org/0000-0002-6956-6913
ORCID Icon,
Yan Wuc Department of Antibody Engineering, Genentech, South San Francisco, CA, USA
&
Minhong Yana Department of Molecular Oncology, Genentech, South San Francisco, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6126-9714
ORCID Icon show all
Article: 1685832 | Received 25 Jul 2019, Accepted 24 Oct 2019, Published online: 18 Dec 2019

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rebecca P Chen, Kenta Shinoda, Pragya Rampuria, Fang Jin, Tin Bartholomew, Chunxia Zhao, Fan Yang & Javier Chaparro-Riggers. (2022) Bispecific antibodies for immune cell retargeting against cancer. Expert Opinion on Biological Therapy 22:8, pages 965-982.
Read now

Articles from other publishers (7)

Zhang-zhao Gao, Jing-yu Jiao, Ya-qiong Zhou, Jian Qi, Shan-shan Zhu, Jing-ya Xu, Lei Nie & Hai-bin Wang. (2023) A novel monospecific tetravalent IgG1-(scFv)2 version shown enhanced neutralizing and Fc-mediated effector functions against SARS-CoV-2. 3 Biotech 13:8.
Crossref
Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Seyed H. Ghaffari & Davood Bashash. (2022) Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy. International Immunopharmacology 103, pages 108499.
Crossref
Austin Le Lam & Bryan Heit. (2021) Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes. Cells 10:5, pages 1265.
Crossref
Siqi Chen, Seigmund W. T. Lai, Christine E. Brown & Mingye Feng. (2021) Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy. Frontiers in Immunology 12.
Crossref
Marie-Astrid Boutet, Gabriel Courties, Alessandra Nerviani, Benoit Le Goff, Florence Apparailly, Costantino Pitzalis & Frédéric Blanchard. (2021) Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmunity Reviews 20:3, pages 102758.
Crossref
Justus M. Huelse, Diana M. Fridlyand, Shelton Earp, Deborah DeRyckere & Douglas K. Graham. (2020) MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system. Pharmacology & Therapeutics 213, pages 107577.
Crossref
Steffen Dickopf, Guy J. Georges & Ulrich Brinkmann. (2020) Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies. Computational and Structural Biotechnology Journal 18, pages 1221-1227.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.